Short Interest in Sunshine Biopharma, Inc. (NASDAQ:SBFMW) Decreases By 76.6%

Sunshine Biopharma, Inc. (NASDAQ:SBFMW) was the recipient of a significant drop in short interest during the month of May. As of May 29th, there was short interest totaling 1,317 shares, a drop of 76.6% from the May 14th total of 5,626 shares. Based on an average daily volume of 26,884 shares, the days-to-cover ratio is presently 0.0 days.

Sunshine Biopharma Trading Down 48.7%

Shares of NASDAQ:SBFMW traded down $0.02 during trading on Thursday, hitting $0.03. The stock had a trading volume of 1,006 shares, compared to its average volume of 10,920. Sunshine Biopharma has a 12-month low of $0.03 and a 12-month high of $0.65. The stock has a 50-day simple moving average of $0.12 and a two-hundred day simple moving average of $0.15.

Sunshine Biopharma Company Profile

Sunshine Biopharma is a development-stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics for oncology and antiviral applications. The company’s research activities encompass the design, synthesis and preclinical evaluation of compounds that inhibit key pathways involved in cell proliferation and viral replication.

Among its lead programs, Sunshine Biopharma is advancing Adva-27a, a topoisomerase II inhibitor licensed from the National Research Council of Canada, which is undergoing preclinical studies for potential use in breast and ovarian cancers.